Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-08-000932
Filing Date
2008-02-13
Accepted
2008-02-13 17:29:38
Documents
7
Period of Report
2007-10-31

Document Format Files

Seq Description Document Type Size
1 c52319_10k.txt 10-K 349780
2 c52319_ex10-26.txt EX-10.26 10697
3 c52319_ex21.txt EX-21 590
4 c52319_ex31-1.txt EX-31.1 3162
5 c52319_ex31-2.txt EX-31.2 3117
6 c52319_ex32-1.txt EX-32.1 1543
7 c52319_ex32-2.txt EX-32.2 1548
  Complete submission text file 0000930413-08-000932.txt   372307
Mailing Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309
Business Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309 954-486-4590
Synovics Pharmaceuticals (Filer) CIK: 0001030839 (see all company filings)

EIN.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-22011 | Film No.: 08606406
SIC: 2833 Medicinal Chemicals & Botanical Products